Cargando…
Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells
CDC25 phosphatases are important regulators of the cell cycle and represent promising targets for anticancer drug discovery. We recently identified NSC 119915 as a new quinonoid CDC25 inhibitor with potent anticancer activity. In order to discover more active analogs of NSC 119915, we performed a ra...
Autores principales: | Capasso, Alessandra, Cerchia, Carmen, Di Giovanni, Carmen, Granato, Giuseppina, Albano, Francesco, Romano, Simona, De Vendittis, Emmanuele, Ruocco, Maria Rosaria, Lavecchia, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741889/ https://www.ncbi.nlm.nih.gov/pubmed/26474275 |
Ejemplares similares
-
Inhibition mechanism of naphthylphenylamine derivatives acting on the CDC25B dual phosphatase and analysis of the molecular processes involved in the high cytotoxicity exerted by one selected derivative in melanoma cells
por: Aliotta, Federica, et al.
Publicado: (2020) -
In Silico Identification of Novel Inhibitors Targeting the Homodimeric Interface of Superoxide Dismutase from the Dental Pathogen Streptococcus mutans
por: Cerchia, Carmen, et al.
Publicado: (2022) -
Novel Reversible Inhibitors of Xanthine Oxidase Targeting the Active Site of the Enzyme
por: Rullo, Rosario, et al.
Publicado: (2023) -
Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
por: Brenner, Annette K., et al.
Publicado: (2014) -
In Silico Drug Design and Discovery: Big Data for Small Molecule Design
por: Cerchia, Carmen, et al.
Publicado: (2022)